Therefore, the inhibition of lncRNAs can be introduced as a suitable therapeutic strategy to reduce the breast tumor growth by suppression of PI3K/AKT, MAPK, and TGF-β signaling pathways. The gene discussed is PIK3CA; the disease is breast neoplasm.